Search hospitals > West Virginia > Princeton

Princeton Community Hospital

Claim this profile
Princeton, West Virginia 24740
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Colon Cancer
Conducts research for Colorectal Cancer
Conducts research for Cancer
31 reported clinical trials
5 medical researchers
Photo of Princeton Community Hospital in PrincetonPhoto of Princeton Community Hospital in PrincetonPhoto of Princeton Community Hospital in Princeton

Summary

Princeton Community Hospital is a medical facility located in Princeton, West Virginia. This center is recognized for care of Breast Cancer, Breast cancer, Colon Cancer, Colorectal Cancer, Cancer and other specialties. Princeton Community Hospital is involved with conducting 31 clinical trials across 50 conditions. There are 5 research doctors associated with this hospital, such as Nour Daboul, Sobha Kurian, Rowena Gonzales-Chambers, and Bei Jiang.

Area of expertise

1Breast Cancer
Global Leader
Princeton Community Hospital has run 14 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
ER negative
2Breast Cancer
Princeton Community Hospital has run 9 trials for Breast cancer. Some of their research focus areas include:
HER2 negative
ER positive
ER negative

Top PIs

Clinical Trials running at Princeton Community Hospital

Ovarian Cancer
Breast Cancer
Breast cancer
Cancer
Colon Cancer
Rectal Cancer
Lobular Carcinoma in Situ
Ductal Carcinoma In Situ
Peritoneal Adenocarcinoma
Peritoneal Serous Adenocarcinoma
Image of trial facility.

Olaparib +/- Bevacizumab

for Ovarian Cancer

This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Surgical Procedures

for Reducing Ovarian Cancer Risk

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Princeton Community Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security